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ABSTRACT Epstein-Barrvirus(EBV),amemberoftheherpesvirusfamily,isthecausativeagentofcommonhumaninfections
andspeciﬁcmalignancies.EBVentryintotargetcells,includingBcellsandepithelialcells,requirestheinteractionofmultiple
virus-encodedglycoproteins.GlycoproteinsHandL(gH/gL)cooperatewithglycoproteinB(gB)tomediatefusionoftheviral
envelopewithtargetcellmembranes.BoththegH/gLcomplexandgBarerequiredforfusion,whereasglycoprotein42(gp42)
actsasatropismswitchandisrequiredforBcellinfectionandinhibitsepithelialcellinfection.Ourpreviousstudiesidentiﬁeda
prominentKGDmotiflocatedonthesurfaceofgH/gL.Inthecurrentstudy,wefoundthatthismotifservesasabifunctional
domainonthesurfaceofgH/gLthatdirectsEBVfusionofBcellsandepithelialcells.MutationoftheKGDmotiftoAAAde-
creasedfusionwithbothepithelialandBcellsandreducedthebindingofgH/gLtoepithelialcellsandtogp42.Wealsodemon-
stratethatdeletionofaminoacids62to66ofgp42selectivelyreducesbindingtowild-typegH/gL,butnottheKGDmutant,sug-
gestingthattheKGDmotifofgH/gLinteractswiththeN-terminalaminoacids62to66ofgp42.
IMPORTANCE EpithelialandBcellsarethemajortargetsofEpstein-Barrvirus(EBV)infectioninthehumanhost.EBVutilizes
differentglycoproteincomplexestoenterthesecelltypes.ForBcellfusion,EBVusescomplexescontaininggp42,gH/gL,andgB,
whereasjustgH/gLandgBarerequiredforepithelialcellfusion.Inthecurrentstudy,abifunctionaldomainconsistingofa
prominentKGDmotifonthesurfaceofthegH/gLstructurewasidentiﬁed;thisdomainaffectsinteractionswithgp42orepithe-
lialreceptors,ultimatelydictatingwithwhichcelltypevirus-inducedfusioncanoccur.Thesestudieswillleadtoabetterunder-
standingofthemechanismofEBV-inducedmembranefusionandherpesvirus-inducedmembranefusioningeneral.
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E
pstein-Barr virus (EBV) is one of eight known human herpes-
virusesandisamemberoftheGammaherpesviridaesubfamily
(1).EBVhasahighprevalenceinhumans,withmorethan90%of
the population latently infected with the virus (1). Typically, in-
fection during childhood is asymptomatic, but infection in ado-
lescents can result in the development of infectious mononucleo-
sis. Virions are transmitted by saliva resulting in the infection of
epithelial cells of the oral pharynx. Transmission by sexual, trans-
fusion, and transplantation routes has also been reported (2, 3).
Following transmission, the virus infects B cells and establishes
latencyinmemoryBcellswhereitpersistsindeﬁnitely(4,5).EBV
is associated with a variety of hematopoietic cancers, such as
Burkitt’s lymphoma and Hodgkin’s lymphoma. EBV is also asso-
ciated with lymphoproliferative disorders in patients with im-
mune dysfunction such as HIV/AIDS or in patients undergoing
immune suppression for organ transplantation (2, 6). Entry into
target cells is an essential step for EBV to cause disease. EBV entry
is a complex process requiring the cooperation of multiple glyco-
proteins and cell surface receptors and ultimately resulting in fu-
sionofthevirionenvelopeeitherbydirectfusionwiththeplasma
membrane or following endocytosis (7, 8).
BcellsandepithelialcellsaretwomajortargetcellsofEBV(1).
However, different glycoproteins are involved in B cell and epi-
thelialcellentryandfusion.GlycoproteinB(gB),theglycoprotein
H and L (gH/gL) complex, and glycoprotein (gp42) are required
forEBVfusionofBcells,whileonlygBandthegH/gLcomplexare
required for EBV fusion of epithelial cells (7, 9). Cleaved secreted
gp42 can trigger viral fusion with B cells in the absence of
membrane-bound gp42, while virus lacking gp42 can bind to B
cellsbutisnotabletoinfectthem(10).TheinitialattachmenttoB
cellsismediatedbytheinteractionofgp350/220withcomplement
receptor2(CR2)whichisalsodesignatedCD21(11,12).Previous
studies have shown that gp42 and gH/gL form a stable complex
(13, 14). Interestingly, soluble gp42 can inhibit viral fusion with
epithelial cells, which suggests that the site on gH/gL that gp42
binds is an important site for epithelial cell entry (9). Further
support of a bifunctional domain on gH/gL that is required for
gp42 binding to gH/gL and gH/gL-mediated epithelial cell entry
results from the identiﬁcation of N-terminal gp42 peptides that
can block both B cell and epithelial cell entry and fusion (15).
Thefunctionofgp42inBcellentryandfusionhasbeenexten-
sively studied using site-speciﬁc mutations based on the crystal
structures of gp42 unbound and bound to the B cell receptor hu-
manleukocyteantigenclassII(HLAclassII)(16,17).Tworegions
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One is a hydrophobic pocket that is widened in response to HLA
classIIbinding.TheotheristheN-terminalregion,whichprojects
outward from the C-type lectin domain in a path that is distinct
from that observed in the HLA-bound structure. These observed
conformational changes of gp42 following interaction with HLA
classIIhaveledtothemodelthataconformationalchangeingp42
triggers fusion required for B cell infection (7, 16).
AllhumanherpesviruseshavethegH/gLcomplexthatisessen-
tial for membrane fusion and infection (7). gL is a chaperone
proteinthatisessentialforthecorrectfoldingandtransportofgH
tothecellsurface(18,19).ThegH/gLcomplexisindispensablefor
epithelialcellfusion(9,19).EBVvirionslackinggHcannotattach
to epithelial cells, and soluble gH/gL can bind epithelial cells (20,
21). This indicates that there is a receptor for gH/gL on epithelial
cells and that interaction with the receptor is required for epithe-
lial cell fusion. Recently, the putative epithelial cell receptor of
gH/gL was identiﬁed as the integrins v6 and v8. Soluble
forms of integrins v6 and v8 coprecipitate with soluble
gH/gLandinducefusionwithcellsexpressinggH/gLandgB(22).
The crystal structure of the gH/gL complex was recently resolved
and indicated that the gH/gL complex is composed of four do-
mains, forming a ﬂat elongated shape with individual domains
arranged in tandem along the length of the molecule (23). Inter-
estingly,anintegrinbindingmotif,KGD,isfoundprominentlyon
thesurfaceofthegH/gLstructureinanexposedloopindomainII
(D-II) (23).
Previous studies have shown that EBV glycoprotein-mediated
membranefusionwithepithelialcellscanbeblockedbysaturating
amountsofeithergp42orshortgp42-derivedpeptides(15).How-
ever, how gp42 blocks epithelial cell fusion is still unclear. The
prevailing hypothesis is that the binding of gp42 to gH/gL masks
theregionofgH/gLthatbindstoreceptorsonepithelialcells.With
the identiﬁcation of integrins as epithelial cell receptors for EBV
gH/gLandidentiﬁcationofaKGDmotiflocatedonthesurfaceof
the gH/gL crystal structure, we hypothesize that soluble gp42
binding to the KGD motif of gH/gL prevents the integrin-
dependent fusion with epithelial cells. To test this hypothesis. we
constructedagH/gLmutantinwhichtheKGDmotifwasmutated
to triple alanine (gH-AAA). This mutant was tested for its fusion
function in epithelial and B cells and its association with gp42.
After mutation of the KGD motif, fusion mediated by gH/gL was
decreased in both B cells and epithelial cells with a concomitant
decrease in binding to gp42 and epithelial cells. By examining the
associationofgH/gLandgH-AAA/gLwithgp42deletionmutants,
wefoundthatthegH/gLKGDmotifinteractswithaminoacids62
to 66 located within the gp42 N terminus.
RESULTS
TheproposedintegrinbindingmotifKGDofEBVgH/gLisim-
portant for epithelial and B cell fusion. To investigate whether
the prominent KGD motif present on the gH/gL structure repre-
sents a bifunctional binding domain that interacts with gp42 and
integrins, a triple alanine mutation (AAA) in the KGD motif
(amino acids 188 to 190) of gH (gH-AAA) was constructed. We
ﬁrst investigated the fusion function of the gH-AAA mutant in
epithelial cells. Effector CHO-K1 cells were transfected with a lu-
ciferase reporter construct under the control of a T7 promoter
(T7-luciferase) and the glycoproteins essential for epithelial cell-
cellfusion,gBandgH/gLorgH-AAA/gLasindicatedinFig.1.The
effector cells were then overlaid with human embryonic kidney
293 (HEK 293) target cells stably expressing T7 polymerase, and
FIG 1 The KGD motif of gH is required for EBV fusion with epithelial and
DaudiBcells.CHO-K1cellsweretransientlytransfectedwiththeT7luciferase
plasmidalone(control)orwiththeT7luciferaseplasmid,EBVgB,gL,together
with gH or gH-AAA mutant with or without gp42, as indicated. (A and B)
Transfected CHO-K1 cells were overlaid with epithelial cells expressing T7
polymerase (A) or Daudi B cells expressing T7 polymerase (B). Luciferase
activity was normalized to cells with wild-type (WT) gH/gL levels, which was
set at 100%. The data are means plus standard deviations (SD) (error bars)
from three independent experiments.
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used as epithelial target cells since they fuse with effector cells in
the absence of gp42 (24). We found that the gH-AAA/gL mutant
had decreased fusion efﬁciency with HEK 293 cells (Fig. 1A),
which is compatible with the putative role of the KGD motif of
gH/gL interacting with the integrins v6 and v8 required for
epithelial cell entry (22, 25). Along with these experiments, we
conﬁrmed the inhibitory effect of gp42 on epithelial cell-cell fu-
sion (15, 26). In the presence of gp42, fusion with epithelial cells
decreased about 40% (Fig. 1A).
Daudi is a human B cell lymphoma cell line for which fusion
with effector cells is dependent on gp42 (27, 28). For Daudi B cell
fusion, gp42 was transfected in addition to gH/gL and gB into the
CHO-K1 cells. Interestingly, the gH-AAA mutation also de-
creased fusion activity with Daudi B cells by about 80% (Fig. 1B),
suggesting a role for this motif in binding gp42 required for B cell
fusion. CHO-K1 cells without gp42 (Fig. 1B, rightmost bar) show
no fusion activity, which indicates the requirement of gp42 for
Daudi B cell fusion.
MutationofthegH/gLKGDmotifresultsinreducedbinding
ofgH-AAA/gLtoepithelialcellsandgp42.Todeterminewhythe
KGDmotifwasimportantforbothepithelialcellandBcellfusion,
we compared the binding of wild-type (wt) gH/gL and gH-
AAA/gL to AGS cells and HEK 293 cells. Both AGS cells and HEK
293 cells have been widely used in EBV epithelial cell-cell fusion
and entry assays (22, 26). We transfected Chinese hamster ovary
CHO-K1 cells with control plasmid, wt gH/gL, or gH-AAA/gL,
lysed the cells by freeze-thawing, and collected the supernatants
containing solubilized gH/gL. The supernatants were overlaid on
AGSorHEK293cells,andgH/gLbindingtothecellswasdetected
by cell enzyme-linked immunosorbent assay (CELISA). The mu-
tantgH-AAA/gLhaddecreasedbindingtoAGSandHEK293cells
compared with the wt gH/gL (Fig. 2A). To exclude the possibility
thatthegH-AAA/gLmutantwasexpressedatlowerlevelsthanwt
gH/gL, we veriﬁed the cell surface expression of wt or mutant
gH/gLpriortopreparingthecelllysatesandfoundtheexpression
levels comparable (Fig. 2B). These data indicate that the gH-
AAA/gL has reduced binding to epithelial cells compared to wt
gH/gL and that this decreased cell surface binding correlates with
the decreased epithelial cell fusion activity.
Previous studies have shown that the association of gp42 with
gH/gL is crucial for B cell fusion and the essential binding site on
gp42 for gH/gL is contained within the gp42 amino terminus (14,
15).SincethegH-AAA/gLmutantalsoexhibiteddecreasedfusion
activity for B cells (Fig. 1B), we examined the binding of a Flag-
tagged soluble form of gp42 (29) to wt gH/gL and gH-AAA/gL
expressedonthecellsurfacesofCHO-K1cells.Supernatantscon-
taining soluble Flag-tagged gp42 were applied to cells transfected
with gH/gL, the cells were extensively washed, and gp42 binding
was determined by Western blotting. Despite observing equal
amountsofgLandcontrollingforequivalenttotalproteinloading
by monitoring glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Fig. 3A, middle and bottom panels), we found that
cells expressing the gH-AAA/gL mutant had signiﬁcantly de-
creasedgp42binding(Fig.3A,toppanel),indicatingthattheKGD
motif is also important for the binding of gp42 with gH/gL.
To conﬁrm that the binding site on gH/gL is also the binding
site for gp42, we examined whether soluble gp42 blocks the bind-
ing of gH/gL or gH-AAA/gL to epithelial cells. Supernatants con-
taining solubilized gH/gL or gH-AAA/gL were preincubated with
media only or media containing soluble gp42 for1ha t4 ° Ca n d
thenoverlaidontoHEK293cells.CELISAwasthenusedtodetect
gH/gLorgH-AAA/gLbindingtotheHEK293cells.Theresultsin
Fig.3Bdemonstratethatsolublegp42decreasedgH/gLbindingto
FIG 2 gH binding with AGS and HEK 293 cells was decreased in the gH-
AAA/gL mutant. CHO-K1 cells were transiently transfected with control, gH/
gL, or gH AAA/gL. (A) Soluble gH/gL and gH-AAA-gL were prepared as de-
scribed in Materials and Methods and used to overlay with AGS cells or HEK
293 cells in 96 wells in triplicate. After incubation for 4 hours at 4°C, binding
was examined by CELISA. (B) In parallel, the transfected cells were examined
for gH/gL and gH-AAA/gL expression and were found to be similar. Twenty-
four hours posttransfection, 4  104 cells were seeded into 96-well plates in
triplicate.CELISAwasperformedwithanti-gH/gLantibody(Ab)(E1D1).The
data are means plus SD from three independent experiments.
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gp42 also further decreased the binding of gH-AAA/gL to epithe-
lial cells approximately 40% of gH-AAA/gL levels and approxi-
mately25%ofwild-typegH/gLlevels.Theseobservationsindicate
that the gH/gL KGD motif constitutes an important functional
domain of gH/gL that directs binding to gp42.
FIG 3 The KGD motif is involved in interaction of gH/gL with gp42. (A) The gH-AAA/gL mutant has decreased association with gp42. CHO-K1 cells seeded
in six-well plates were transfected with control, gH/HA-gL, or mutant gH-AAA/HA-gL. Twenty-four hours posttransfection, the cells were washed twice with
ice-coldPBSandincubatedwithmediacontainingFlag-taggedgp42(isolated24haftertransfection)for1hat4°C.Thecellswerethenwashedwithice-coldPBS
four times and lysed with 200 lo f1  SDS lysis buffer. Proteins were separated on 10% SDS-polyacrylamide gels. Western blot analyses were performed using
the polyclonal anti-Flag antibody (F7425) at 1:1,000 to detect the Flag-gp42 that bound to the transfected cells. Anti-GAPDH and anti-HA (gL-HA) were used
as loading controls. The data are representative of three independent experiments. (B) Soluble gp42 can decrease the binding of gH/gL with epithelial cells.
CHO-K1 cells were transiently transfected with control, gH/gL, or gH-AAA/gL. Twenty-four hours posttransfection, 2  106 cells were collected, and soluble
gH/gL or gH-AAA/gL was prepared. Soluble gp42 was added as described in Materials and Methods. Binding of gH/L or gH-AAA/gL to HEK 293 cells was
measuredfollowingoverlayofHEK293cellswithsolublegH/gLorgH-AAA/gLwithorwithoutsolublegp42for4hat4°CfollowedbydetectionofgHbinding
by CELISA with gH/gL antibody E1D1. The data are means plus SD from three independent experiments.
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thegHKGDmotiftobindgH/gL.Inpreviousstudies,wemapped
the amino-terminal residues of gp42 that bind gH/gL (14, 15).
From these studies, two contiguous regions of the N terminus of
gp42 from approximately amino acids 36 to 61 and 67 to 81 were
found to directly bind to gH/gL. A short stretch of amino acids
(amino acids 62 to 66), which separated these two regions, was
foundtocontributetothehigh-afﬁnitybindingofgp42togH/gL.
In order to further delineate the region of gp42 that binds the
gH/gL KGD motif, we chose a group of mutants from previously
constructed 5-amino-acid deletion mutants within the gp42
amino terminus. We were most interested in testing mutants that
still bound gH/gL (mutant in which amino acids 42 to 46 were
deleted[d42-46],d62-66,andd72-76)todeterminewhetherthere
was any change in the binding of the gp42 mutants to the gH-
AAA/gL mutant. We also chose mutants that we had previously
shown did not bind gH/gL (d57-61, d67-71, and d77-81) as con-
trols (14, 15). The mutants were ﬁrst expressed in CHO-K1 cells,
supernatants containing soluble gp42 were collected, and expres-
sionofeachmutantandwild-typegp42wasfoundtobesimilarby
SDSgelelectrophoresis(Fig.4A).Themediumsupernatantswere
then used in a monolayer cell binding assay to determine binding
of each mutant to control transfected cells, wt gH/gL-transfected
cells,orgH-AAA/gLmutanttransfectedcells(Fig.4B).Inallcases,
there was no binding of wt gp42 or the gp42 mutants to control
transfected cells (Fig. 4B, lanes 1, 4, 7, 10, 13, 16, and 19). In
addition, we found that d57-61, d67-71, and d77-81 did not asso-
ciate with wt gH/gL or mutant gH-AAA/gL (Fig. 4B, lanes 8, 9, 14
and15,and20and21)consistentwiththepreviousCELISAstud-
ies with soluble gH/gL (15). Interestingly, the d42-46 and d72-76
mutants still associated with wt gH/gL, but less gp42 was present
in the gH-AAA/gL mutant compared to wt gp42, suggesting that
these two gp42 mutants bind with lower afﬁnity to the gH-
AAA/gL mutant (Fig. 4B, lanes 5 and 6 and lanes 17 and 18). The
most interesting gp42 deletion mutant was the gp42 d62-66 mu-
tant(Fig.4B,lanes11and12).Asdescribedabove,previousstud-
ies had suggested that this region constitutes a linker separating
thetwodomainsofgp42thatareimportantforhigh-afﬁnitybind-
ing to gH/gL. This mutant had a nearly identical binding proﬁle
for wt gH/gL and the gH-AAA/gL mutant in contrast to wt gp42
and the gp42 mutants d42-46 and d72-76 in which a reduction of
gp42 binding was observed for gH-AAA/gL compared with gH/
gL. The quantiﬁed ratio of the associated gp42 d62-66 mutant
withgH-AAA/gLcomparedwithgH/gLwasapproximately1,and
FIG 4 Amino acids 62 to 66 of gp42 are important for gp42 interaction with the KGD motif of gH/gL. CHO-K1 cells seeded in six-well plates were transfected
withcontrol(lanes1,4,7,10,13,16,and19inpanelB),gH/gL(lanes2,5,8,11,14,17,and20inpanelB),orgH-AAA/gL(lanes3,6,9,12,15,18,and21inpanel
B). Twenty-four hours after transfection, the cells were washed twice with ice-cold PBS and incubated with media containing gp42 or gp42 deletion mutants as
indicatedinpanelA,lanes1to7(isolatedafter24htransfection)for1hat4°C.(B)Thecellswerethenwashedwithice-coldPBSfourtimesandlysedwith200l
of 1 SDS lysis buffer. 2 SDS lysis buffer was added to the media containing gp42 or gp42 deletion mutants. Samples were separated on 10% SDS-
polyacrylamidegels.Westernblotanalyseswereperformedusingthepolyclonalanti-gp42antibody(pb1112)at1:1,000dilution.Thegp42d62-66(aminoacids
62 to 66 deleted) mutant is deleted for two potential N-linked glycosylation sites, which results in a change in gp42 migration as previously described (28).
GAPDH was used as the loading control. The data are representative of three independent experiments. Associated gp42 or mutant gp42 with gH/gL or
gH-AAA/gL was quantiﬁed and normalized against GAPDH loading control using Quantity One software (version 4.3.1; Bio-Rad). The quantiﬁed data were
expressed as the average of three independent experiments as indicated underneath the blot (ratio of the amount of associated gp42 with gH-AAA/gL to the
amount of associated gp42 with gH/gL).
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d72-76 with gH-AAA/gL compared with gH/gL was less than 0.5
(Fig. 4B). The d62-66 mutant selectively reduces binding to wild-
type gH/gL to comparable levels of the gH-AAA/gL mutant. This
suggests that the linker deletion mutant in gp42 and the AAA
mutationingH/gLhavesimilareffectsinreducingthegp42inter-
action with gH/gL and that these two mutations are not additive.
ThesesitesingH/gLandgp42mayeitherinteractdirectlyorprop-
agate their binding effects through a common, nearby site on gH/
gL.TheseresultsindicatethattheKGDmotifreliesonaminoacids
62 to 66 of gp42 for binding to gH/gL. Compatible with observed
binding, this mutant was reduced in fusion function with B cells
(approximately50%ofwtgp42)andexhibitedreducedbindingto
gH/gL in immunoprecipitation and in a cell-based binding assay
(15).
The gp42 d62-66 mutant is impaired in blocking epithelial
cellfusion.Tofurtherinvestigatewhetheraminoacids62to66of
gp42 may bind the gH/gL KGD motif, we examined whether this
mutant was impaired in blocking HEK 293 cell fusion (Fig. 5).
Thismightbeexpectedifthed62-66deletionmutantfailstobind
theKGDmotifofgHandmakestheKGDmotifofgH/gLavailable
to bind the integrin receptor on epithelial cells required for EBV
epithelialfusion.Forthisexperiment,wemonitoredHEK293and
Daudi cell fusion following transfection of increasing amounts of
wtgp42andthegp42d62-66mutant.Asexpected,forDaudicells,
there was in general an increase in cell fusion with increasing
FIG5 The 62-66 motif of gp42 is essential for inhibiting EBV fusion with epithelial cells. CHO-K1 cells were transiently transfected with T7 luciferase plasmid
alone (control) or T7 luciferase plasmid, EBV gB, gH, and gL together with increasing amounts (in micrograms) of gp42 or gp42 d62-66. (A and B) Transfected
CHO-K1 cells were overlaid with Daudi B cells (A) or epithelial cells (B), and luciferase activity was measured. (C and D) Expression of gp42, gp42 d62-66, and
gH/gL.After24hoftransfection,4104cellswereseededinto96-wellplatesintriplicate.CELISAwasperformedwithanti-gp42Ab3T3(C)orwithanti-gH/gL
Ab (E1D1) (D). The values are shown as percentages of the value for 2.0 g or no gp42 as shown on the y axes. The data are representative of three independent
experiments.
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gp42 d62-66 mutant were lower than for the wt gp42, similar to
whatwaspreviouslypublished(Fig.5A)(15).Incontrast,wtgp42
but not gp42 d62-66 had an inhibitory effect on epithelial cell
fusion (Fig. 5B). We also checked the cell surface expression of
gp42,gp42d62-66,andgH/gLinthetransfectedcellsusedforcell
fusion shown in Fig 5A and B and as expected found a modest
increase in the expression of gp42, gp42 d62-66, and gH/gL when
increasing amounts of DNA were transfected (Fig. 5C and D).
Thus, in contrast to wt gp42, the gp42 d62-66 mutant does not
inhibit epithelial cell fusion, since it lacks a key gp42 domain im-
portant for binding the gH/gL KGD motif.
DISCUSSION
In the current study, we investigated the role of the gH/gL KGD
motif implicated in integrin and gp42 binding. The motif is lo-
cated in a prominent loop on the surface of the gH/gL structure
and is contained in D–II near the domain I/domain II (D-I/D-II)
linker -helix (2-1) and maps near the D–I/D–II interface. Pre-
vious mutations in both gH and gL, including gH residue 74,
which maps to a hydrophobic groove adjacent to the KGD motif,
altered the activity of gH/gL, suggesting a role for this region in
EBV glycoprotein entry function (23, 30). The gH/gL KGD motif
has been hypothesized to be important for the interaction of
gH/gL with v6 and v8 integrins triggering fusion of epithe-
lial cells (22). The observation that gp42 blocks EBV entry into
epithelial cells (9, 15, 31) suggests that the KGD motif and/or the
area surrounding it may also be important for gp42 binding to
gH/gL.Ithasbeensuggestedthatgp42inhibitsepithelialfusionby
occluding the epithelial receptor binding domain of gH/gL (9, 13,
15). The importance of gp42 binding to gH/gL for B cell entry is
evident,sincepreviousstudieshaveshownthatmutationsingp42
thatblockgp42bindingtogH/gLblockEBV-inducedBcellmem-
branefusion(15).TofurtherinvestigatetheroleoftheKGDmotif
in membrane fusion, we mutated the KGD motif by constructing
a triple alanine mutant and found that this region was important
for epithelial cell fusion and also important for B cell fusion. A
mutant in the KGD motif of gH/gL exhibited reduced binding to
epithelialcellsandboundpoorlytogp42.Inaddition,wefoundby
analyzing a group of gp42 N-terminal deletion mutants, that
amino acids 62 to 66 contribute to the binding of gp42 to gH/gL,
likely by speciﬁcally interacting with the gH/gL KGD motif.
Our current studies suggest that the KGD motif of gH/gL is a
bifunctional domain that mediates EBV fusion of epithelial cells
and B cells through interactions with gp42 and the EBV epithelial
cell receptor. The interaction of gp42 with gH/gL is complex, re-
quiring two domains within the gp42 amino terminus (approxi-
mately amino acids 36 to 61 and 67 to 81) separated by a short
linker region from amino acids 62 to 66 (14, 15). The gp42 amino
terminus containing this region was disordered in the two gp42
structures representing gp42 unbound and bound to the gp42
receptorHLAclassII(16,17).Previousstudies,bothwithdeletion
mutagenesis and peptides from the gp42 amino terminus, have
suggestedthatthelinkerregionisnotimportantforspeciﬁcinter-
actions with gH/gL, but rather link the two gp42 gH/gL binding
domains (14, 15). Interestingly, when the mutation of the KGD
motif was tested by comparing the gp42 d62-66 mutant to the wt
gH/gL,therewasnodifferenceinthebindingofthisgp42mutant
to the gH-AAA/gL mutant compared to wt gH/gL, in which a
reductioninbindingwasobserved.Theseresultsindicatethatthe
KGDmotifatleastplayssomepartinbindingaminoacids62to66
of gp42. The binding of this linker region to gH/gL may be medi-
ated by speciﬁc side chain interactions or structural features at or
around the KGD motif found on the gH/gL surface. In the gH/gL
structure,thereisalargegroovelocatedbetweentheD-IandD-II
domainsthatwehavehypothesizedmaybeinpartthebindingsite
for gp42. Thus, the adjacent location of the KGD motif to this
groove and the observation that the KGD motif plays a bifunc-
tional role in epithelial cell fusion and B cell fusion makes this
hypothesis attractive. For the interaction of gH/gL with the v6
and v8 integrin epithelial receptors, the presence of the KGD
motif provides a mechanism for gH/gL to speciﬁcally bind to in-
tegrins as previously shown (22, 25). RGD or KGD motifs are
typical recognition sequences for integrins, while adjacent amino
acidscanincreaseafﬁnity(32,33).Structuralandfunctionalstud-
ies have shown that the interaction of integrins with RGD motif
proteins (or peptides) depends primarily on electrostatic, speciﬁc
amino acid side chain interactions, and hydrogen bonds (34).
Other studies have shown that an RGD motif, found in herpes
simplex virus type 1 (HSV-1) gH/gL, binds to v3 integrins.
Mutating the RGD motif of HSV-1 gH/gL abolished gH/gL bind-
ing to Vero cells (35, 36). Previous mutations in foot-and-mouth
disease virus of this motif also block function (37), compatible
with the observation of loss of function for epithelial fusion and
cell binding that we observed for epithelial fusion in the gH-
AAA/gL mutant.
Oneofthemostinterestingobservationsinthecurrentstudyis
theﬁndingthatthissameKGDmotifplaysanimportantroleinB
cell fusion and gp42 binding. The observation that gp42, in part,
dependsontheKGDmotifforgHbindingandfunctioninfusion
is not surprising, since previous studies had suggested that do-
mainsrequiredforBcellandepithelialcellfusionandentryover-
lap.HowtheKGDmotifspeciﬁcallyinteractswiththegp42amino
acids 62 to 66 will require additional studies. Previous studies
demonstrated that gp42- and gp42-derived peptides can block
epithelial and B cell fusion and entry presumably by blocking the
interaction of gH/gL with integrins for epithelial fusion and gp42
for B cell fusion. Similarly, our current results indicate that the
addition of soluble gp42 can inhibit the binding of gH/gL to epi-
thelial cells, indicating that the gH/gL domain for gp42 binding
and epithelial cell binding overlaps. Studies with gp42 peptides
have shown that deletion of the linker domain from a gp42 pep-
tidespanningaminoacids36to81doesnotgreatlyaltertheafﬁn-
ity of the gp42 peptide for gH/gL (14). There was only a modest
change (less than 2-fold) in the afﬁnity of the linker-deleted pep-
tide compared to the full-length peptide as determined by a ﬂuo-
rescencepolarization(FP)assay(14).InhibitionofBcellfusionis
reduced with the linker-deleted peptide in contrast to the inhibi-
tion of epithelial cell fusion which is high for both the full-length
and linker-deleted peptides, indicating that the site on gH/gL re-
quired for epithelial fusion does not exactly overlap the site re-
quired for B cell fusion and presumably gp42 binding. Since our
previous studies had shown that the interaction of gp42 with
gH/gL is complex, requiring multiple interactions extending
throughout gp42 36-81 peptide (gp42 peptide from amino acids
36 to 81), our studies using a smaller gp42 peptide may be more
informative for understanding the results of our current study
(14).Asmallergp42peptide,spanningaminoacids47to81,binds
with nearly the same afﬁnity as the afﬁnity of the 36-81 peptide
anddisplayssimilarinhibitioncharacteristicsofBcellandepithe-
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smallerpeptide,thereisagreaterthan70-foldreductioninafﬁnity
for gH/gL in FP and this peptide does not inhibit B cell or epithe-
lial fusion. Further studies with two double alanine mutations (at
positions 62 and 63 [62-63] and positions 64 and 65) within the
linker region of the 47-81 peptide modestly altered the afﬁnity
(4-fold reduction) or modestly enhanced the afﬁnity (2-fold) of
the peptide for gH/gL, respectively (14). The peptide with en-
hanced afﬁnity for gH/gL had little change in the inhibition of
epithelial and B cell fusion compared to the control peptide. In-
terestingly, inhibition of B cell and epithelial fusion was markedly
reducedforthe62-63doublealaninemutantpeptidecomparedto
the control peptide (14). These results are supportive of a role of
the gp42 linker in binding to gH/gL and interfering with gH/gL-
mediatedinductionoffusionandforbindingofgp42requiredfor
B cell fusion. Our model of the interactions between gp42 and
gH/gL is shown in Fig. 6. Further studies will need to be done to
clarify the interactions between gp42 and gp42 peptides with gH/
gL. In particular, cocrystallization of gp42 or gp42 peptides with
gH/gL would precisely map the relevant interactions and are cur-
rently ongoing. In conclusion, we identiﬁed that the conserved
KGD motif in gH/gL of EBV can interact with a small region
(residues 62 to 66) of gp42. The interaction is crucial for EBV
fusionwithBcellstriggeredbybindingofgp42toHLA.TheKGD
motif is also important for the epithelial cell fusion triggered by
binding of gH/gL with epithelial cell receptors such as integrins.
MATERIALS AND METHODS
Cell culture. Chinese hamster ovary cells (CHO-K1) and AGS cells were
grown in Ham’s F-12 medium (BioWhittaker) containing 10% FetalPlex
animal serum complex (Gemini Bio-Products) and 1% penicillin-
streptomycin (100 U penicillin/ml, 100 g streptomycin/ml; BioWhit-
taker). The Daudi 29 cell line (for B cell fusion) and human embryonic
kidney293(HEK293)cells(forepithelialcellfusion)stablyexpressingT7
RNA polymerase (28, 30) were grown in RPMI 1640 medium with
900g/mlG418(Sigma)andDulbeccomodiﬁedEaglemedium(DMEM)
with zeocin, respectively, containing 10% FetalPlex animal serum com-
plex and 1% penicillin-streptomycin.
Construction. Mutation of the gH KGD motif (amino acids 188 to
190) to AAA in full-length gH was generated by using a QuikChange
site-directed mutagenesis kit (Stratagene). The following primers were
used:forwardprimer(5=-AAGCGAGTGACCGAGGCCGCCGCCGAGC
ATGTGTTGAGCCTG-3=) and reverse primer (5=-CAGGCTCAACACA
TGCTCGGCGGCGGCCTCGGTCACTCGCTT-3=). Sequencing was
donetoconﬁrmthepresenceoftheAAAmutationandtheabsenceofany
other mutations.
Transfection. CHO-K1 cells at 80% conﬂuence were transiently
transfected with the mutants and other glycoproteins essential for fusion,
including gB (0.8 g), gH (0.5 g), gL (0.5 g), gp42 (0.8 g), and a
luciferase reporter plasmid with a T7 promoter (0.8 g) by using Lipo-
fectamine 2000 transfection reagent (Invitrogen) in Opti-MEM (Gibco),
aspreviouslydescribed(38).Equalamountsofgp42andgp42mutantsor
equal amounts of gH/gL and gH-AAA mutant were used in each experi-
ment.
Solubilized gH binding assays. CHO-K1 cells were transfected with
gH/gL or gH-AAA/gL as described above. Twenty-four hours later, 2 
106cellswerecollected,resuspendedin1mlofmedia,subjectedto3cycles
of freeze-thawing in liquid nitrogen, and sonicated for 10 s. Insoluble
cellulardebriswasremovedbycentrifugationat1,500gfor5min.AGS
cellsorHEK293cellswereoverlaidwithclariﬁedsupernatants(100l)in
a96-welldishintriplicate.Afterincubationfor4hat4°C,gH/gLbinding
wasexaminedinacellenzyme-linkedimmunosorbentassay(CELISA)as
describedbelow.Forgp42inhibitionassays,solublegp42wasaddedtothe
clariﬁed supernatants prior to overlaying with HEK 293 cells.
Fusion assay. The virus-free cell-based fusion assay was performed as
describedpreviously(24).Brieﬂy,effectorCHO-K1cellsweretransfected
as described above. Twenty-four hours after transfection, the cells were
detached,countedwithaBeckmanCoulterZ1particlecounterandmixed
1:1 with target cells (Daudi 29 B cells or HEK 293 cells, 0.25  106 per
sample) into a 24-well plate in 1 ml Ham’s F-12 medium. Twenty-
four hours later, the cells were washed twice with phosphate-buffered
saline (PBS) and lysed with 100 l of passive lysis buffer (Promega). Lu-
ciferasewasquantiﬁedinduplicatebytransferring20loflysedcellstoa
96-wellplateandadding100lofluciferaseassayreagent(Promega),and
luminescence was measured on a Perkin-Elmer Victor plate reader.
CELISA.Thecellsurfaceexpressionorcellbindingofvariousmutants
wasdeterminedasdescribedinpreviousreports(38).CHO-K1cellswere
transfected with various glycoproteins and split for use in fusion assays
(describedabove)andCELISA.Twenty-fourhoursaftertransfection,4
104cells/wellweretransferredtoa96-wellplateandincubatedforanother
24 h. The expression of each glycoprotein was evaluated using
conformation-speciﬁc antibodies 3H3 for gp42 and E1D1 for gH/gL. Af-
ter incubation with primary antibody for 30 min and ﬁxation with 2%
formaldehyde and 0.2% glutaraldehyde in PBS for 15 min, biotin-labeled
secondary antibody was added at a dilution of 1:500 for 30 min. After the
cellswerewashed,streptavidin-labeledhorseradishperoxidase(1:20,000)
was incubated with the ﬁxed cells for 30 min. Peroxidase substrate was
added, and the amount of cell surface staining was determined by mea-
surement at 380 nm with Perkin-Elmer Victor plate reader.
Monolayer binding assay. CHO-K1 cells at 80% conﬂuence were
transfected with wild-type Flag-tagged gp42 (Flag-gp42) (29) in three
wells.AnotherthreewellsweretransfectedwithgH/gL,mutantgH-AAA/
gL, or control plasmid using Lipofectamine 2000, as described above.
Twenty-four hours after transfection, the supernatants of the cells trans-
fectedwithFlag-gp42werecollectedandcentrifugedtocollectthesoluble
gp42. The cells transfected with control, gH/gL, or gH-AAA/gL were
washed twice with ice-cold PBS and incubated with Flag-gp42 for1ha t
4°C. The cells were then washed with ice-cold PBS four times and lysed
with 200 l of SDS sample buffer. Proteins were separated on 10% SDS-
polyacrylamide gels after boiling for 10 min under reducing conditions.
Western blot analyses were performed using the polyclonal anti-Flag an-
tibody (F7425; Sigma) diluted 1:1,000, polyclonal anti-gp42 antibody se-
rum (PB1112), polyclonal anti-hemagglutinin (anti-HA) (Santa Cruz) at
1:1,000, or polyclonal anti-GAPDH (Abcam) antibody at 1:1,000.
Western blotting. Protein samples were loaded on a 10% SDS-
polyacrylamide gel. After electrophoresis, proteins were transferred to
nitrocellulose membranes (Schleicher & Schuell, Keene, NH). The blots
were blocked with 5% nonfat dry milk in TBS/T buffer (20 mM Tris-HCl
FIG 6 Model of the bifunctional KGD motif of gH/gL. (A) In epithelial cell
fusion,theKGDmotifbindstointegrinonepithelialcells.(B)InBcellfusion,
theKGDmotifbindstogp42,whichisinpartdependentongp42aminoacids
62 to 66. Soluble wild-type gp42 can inhibit epithelial cell fusion, since when
gp42isboundtogH/gL,thegH/gLKGDmotifisoccluded,preventingbinding
to the epithelial receptor.
Chen et al.
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(RT). The blots were washed with TBS/T buffer and incubated with pri-
mary antibodies overnight at 4°C. Anti-rabbit (Bio-Rad, Hercules, CA)
peroxidase-conjugated secondary antibodies were added to the mem-
branesatadilutionratioof1:3,000,andincubationwascontinuedfor1h
at RT. The protein bands on the membrane were visualized by chemilu-
minescence (Pierce, Rockford, IL) and were measured by densitometry
using Quantity One software (version 4.3.1; Bio-Rad).
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